New guideline for HER2 testing in breast cancer benefits patients and clinicians

[News]

Published today, a Focused Update to the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 (HER2) testing in breast cancer brings new levels of clarity that will benefit patients and clinical teams alike.

More... (https://www.news-medical.net/news/20180531/New-guideline-for-HER2-testing-in-breast-cancer-benefits-patients-and-clinicians.aspx)